Orchestra BioMed’s $110 Million Series D Financing

Paul Hastings LLP advised Orchestra BioMed on the deal.Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the closing of a $110 million…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now